Drugmakers Face Ongoing Vaccine Hesitancy
Update: 2023-05-31
Description
P.M. Edition for May 31. The FDA approves Pfizer’s vaccine for RSV, a deadly respiratory virus. But as Wall Street Journal health business editor Jonathan Rockoff reports, companies are preparing to introduce the shots after resistance to vaccination reached new highs during the pandemic. Annmarie Fertoli hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Comments